Senex Biotechnology: Funding, Investors & Team (Sep 2026)
Senex Biotechnology, Inc. is focused on researching and creating therapeutic drugs for cancer, viral infections, and age-related illnesses. The company develops SNX2 compounds for viral and age-related diseases, as well as supplementary treatments for cancer drugs. They also produce SNX9 inhibitors for cancer treatment. Senex Biotechnology provides treatments for various diseases associated with aging, including Alzheimer's disease, kidney disease, heart disease, and arthritis. Established in 2002, the company is located in Columbia, South Carolina.
Senex Biotechnology has raised $400k across 1 funding round on record, the most recent an undisclosed round of $400k announced in Jan 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Senex Biotechnology Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Senex Biotechnology Funding Rounds
Senex Biotechnology Founders and Leadership Team
No contact details are on record for this team yet.
Senex Biotechnology Funding Compared to Other Biotechnology Startups
Senex Biotechnology's latest round of $400k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Senex Biotechnology in Biotechnology and Columbia
Companies Similar to Senex Biotechnology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Senex Biotechnology Funding FAQs
What does Senex Biotechnology do?
Senex Biotechnology, Inc. is focused on researching and creating therapeutic drugs for cancer, viral infections, and age-related illnesses. The company develops SNX2 compounds for viral and age-related diseases, as well as supplementary treatments for cancer drugs. They also produce SNX9 inhibitors for cancer treatment. Senex Biotechnology provides treatments for various diseases associated with aging, including Alzheimer's disease, kidney disease, heart disease, and arthritis. Established in 2002, the company is located in Columbia, South Carolina.
How much funding has Senex Biotechnology raised?
Senex Biotechnology has raised $400k across 1 round on record. The most recent is an undisclosed round of $400k announced in Jan 2025.
When did Senex Biotechnology last raise funding?
Senex Biotechnology's most recent funding round on record is an undisclosed round of $400k, announced in Jan 2025.
Who founded Senex Biotechnology?
FundedIQ lists Igor Roninson (Founder) at Senex Biotechnology.
Where is Senex Biotechnology headquartered?
Senex Biotechnology is based in Columbia, South Carolina, United States.
How many employees does Senex Biotechnology have?
Senex Biotechnology is in the 11-50 employee band.
How does Senex Biotechnology's funding compare to other Biotechnology startups?
Senex Biotechnology's latest round of $400k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Senex Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Senex Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.